MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517035688 A) filed by Genesis Therapeutics Inc., Burlingame, U.S.A., on April 11, for 'compounds for treating cancer.'
Inventor(s) include Nagle Advait; Stock Nicholas Simon; Swiderski Wojciech Piotr; Feinberg Evan Nathaniel; Sklaroff Ben; Reinus Brandon; Mcalpine Indrawan; Indarte Martin; Burke Christopher P.; Nagamizo Joe Fred; and Van Venrooy Alexis.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The present application relates to compounds of Formula (A) as defined herein and pharmaceutically acceptable salts thereof as well as processes for preparing compounds of Formula (A) and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (A) and pharmaceutically acceptable salts thereof and methods of using the compounds and compositions for treating diseases such as cancer."
The patent application was internationally filed on Sept. 11, 2023, under International application No.PCT/US2023/032420.
Disclaimer: Curated by HT Syndication.
